Kent v. Turning Point Therapeutics, Inc
Kent v. Turning Point Therapeutics, Inc is a federal securities / commodities lawsuit filed on 06/29/2022 in the District Court, D. Delaware. The case was terminated on 08/17/2022.
- Court
- District Court, D. Delaware (D. Del.)
Official Court Website → - Assigned judge
- Richard G. Andrews · 4,097 cases in index
- Docket number
- 1:22-cv-00879
- Cause
- 15:78m(a) Securities Exchange Act
15 U.S.C. § 78m - Nature of suit
- 850 Securities/Commodities
Alleged violations of federal securities or commodities laws. - Jurisdiction
- Federal Question
- Jury demand
- Plaintiff
- Date filed
- 06/29/2022
- Date terminated
- 08/17/2022
1,981 Securities / Commodities cases in this court are indexed here.
Parties
- plaintiff · Kent · 724 cases
- defendant · Turning Point Therapeutics, Inc · 4 cases
Part of a Larger Litigation Pattern
This is one of 5 Securities / Commodities cases in our index naming Turning Point Therapeutics, Inc — a possible mass-tort or coordinated-litigation cluster.
About Securities / Commodities Lawsuits
Securities cases involve alleged violations of federal securities or commodities laws — including fraud, misstatements to investors, insider trading, and shareholder class actions brought under the Securities Act and Securities Exchange Act.
Frequently Asked Questions
What is Kent v. Turning Point Therapeutics, Inc?
Kent v. Turning Point Therapeutics, Inc is a federal securities / commodities lawsuit filed on 06/29/2022 in the District Court, D. Delaware. The case was terminated on 08/17/2022. Securities cases involve alleged violations of federal securities or commodities laws — including fraud, misstatements to investors, insider trading, and shareholder class actions brought under the Securities Act and Securities Exchange Act.
What type of case is this?
It is classified as “Securities / Commodities” under the federal nature-of-suit system. Securities cases involve alleged violations of federal securities or commodities laws — including fraud, misstatements to investors, insider trading, and shareholder class actions brought under the Securities Act and Securities Exchange Act.
What court is the case in?
The case is in the District Court, D. Delaware, docket number 1:22-cv-00879.
When was the case filed?
Kent v. Turning Point Therapeutics, Inc was filed on 06/29/2022. It was terminated on 08/17/2022.
What law is the case brought under?
The docket lists the cause as 15 U.S.C. § 78m.
Other Cases Involving These Parties
Related Securities / Commodities Cases
Source: public U.S. federal court record (docket 63559140).